Form D · Biotechnology
CURAVAC, INC.
Wilmington, DE · CIK 0001677679
Offering snapshot reported Jun 21, 2016 · SEC filing
- Reported sold
- Yet to sell Offering amount: $4.68M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50.2K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $374K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-265446
Sales commission estimate if maximum offering is sold. In addition, Broker may receive 100 shares of common stock as retainer.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Young America Capital, LLC | 150443 |
Source: Form D, filed Jun 21, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Leone Flynn | Director, Executive |
| Nicolas Havelange | Director, Executive |
| Stephane Huberty | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3422 Old Capitol Trail Pmg #905
Wilmington, DE, 19808
Wilmington, DE, 19808